View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Notice Summary

Title:
United Kingdom-Huntingdon: Integrated Contraception and Sexual Health (iCaSH) Clinical Laboratory Diagnostic Service Framework
Document Ref:
36731-2020
Document Type:
Contract Notice - Competitive Dialogue
Published By:
NHS SBS
Date Published:
24 January 2020
Deadline Date:
06 March 2020
Document Source:
Framework/DPS:
Yes
Alert Profile:
Labels:

Notice Abstract

This contract is to cover the delivery of integrated contraception and sexual health (iCaSH) clinical laboratory diagnostic service to locations across the East of England.The contract will identify a provider who shall provide a comprehensive clinical laboratory diagnostic service within an overall system of resilient pathology service provision.Suppliers must first register their interest and complete the selection questionnaire associated with the lot below:Lot 1: Core Clinical Pathology;Lot 2: Digital Pathology;Lot 3: Total (Core Clinical Pathology and Digital Pathology Combined).

Notice Details

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

NHS SBS

Kingfisher House, Hingchingbrooke Business Park

Huntingdon

PE29 6FH

UK

Contact person: Andrew Moore

Telephone: +44 1480398500

E-mail: andrew.moore21@nhs.net

NUTS: UK

Internet address(es)

Main address: https://www.sbs.nhs.uk/

Address of the buyer profile: https://secure.sourcedogg.com/profile/1410ba09-ae18-49c1-b969-a8d28650cf8c

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://secure.sourcedogg.com


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://secure.sourcedogg.com


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Regional or local authority

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Integrated Contraception and Sexual Health (iCaSH) Clinical Laboratory Diagnostic Service Framework

Reference number: SBS19-33

II.1.2) Main CPV code

85111800

 

II.1.3) Type of contract

Services

II.1.4) Short description

This contract is to cover the delivery of integrated contraception and sexual health (iCaSH) clinical laboratory diagnostic service to locations across the East of England.

The contract will identify a provider who shall provide a comprehensive clinical laboratory diagnostic service within an overall system of resilient pathology service provision.

Suppliers must first register their interest and complete the selection questionnaire associated with the lot below:

Lot 1: Core Clinical Pathology;

Lot 2: Digital Pathology;

Lot 3: Total (Core Clinical Pathology and Digital Pathology Combined).

II.1.5) Estimated total value

Value excluding VAT: 4 200 000.00 GBP

II.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

Maximum number of lots that may be awarded to one tenderer: 3

II.2) Description

Lot No: Lot 1

II.2.1) Title

Core Clinical Pathology

II.2.2) Additional CPV code(s)

85111800

II.2.3) Place of performance

NUTS code:

UK

UKH

II.2.4) Description of the procurement

Lot 1: core clinical pathology

The contract will identify a provider who shall provide a comprehensive clinical laboratory diagnostic service within an overall system of resilient pathology service provision that must, but not limited to, provide:

— meet the service needs of the designated contraception and sexual health services,

— act as an enabler for the delivery of clinical services across iCaSH,

— improve overall user and patient experience and optimise the patient journey, and

— improve clinical outcomes and streamline clinical pathways.

Clinical laboratory diagnostic services including:

(i) haematology;

(ii) biochemistry;

(iii) virology;

(iv) microbiology including bacteriology;

(v) immunology;

(vi) cytology with HPV testing where indicated, as per National Cervical Screening Programme guidelines;

(vii) histopathology.

II.2.5) Award criteria

Criteria below:

Quality criterion: Quality / Weighting: 70

Price / Weighting:  30

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 72

This contract is subject to renewal: Yes

Description of renewals:

Initial contract period of 24 months. Two periods of 24 month extensions available. The first period will be agreed by both parties prior to end of the initial period.

II.2.9) Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 4

Objective criteria for choosing the limited number of candidates:

See shortlisting criteria within selection questionnaire notes for completion.

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

The relevant lot specific selection questionnaire for Lot 1: core clinical pathology can be found at:

https://secure.sourcedogg.com/profile/1410ba09-ae18-49c1-b969-a8d28650cf8c/requests/32226

Lot No: Lot 2

II.2.1) Title

Digital Pathology

II.2.2) Additional CPV code(s)

85111800

II.2.3) Place of performance

NUTS code:

UK

UKH

II.2.4) Description of the procurement

Lot 2: digital pathology

The contract will identify a provider who shall provide an online patient facing platform ordering of sexual health screening kits (Express Test Home STI Kit) for delivery to chosen destination service provision that must, but not limited to, provide:

— meet the service needs of the designated contraception and sexual health services,

— act as an enabler for the delivery of clinical services across iCaSH,

— improve overall user and patient experience and optimise the patient journey, and

— improve clinical outcomes and streamline clinical pathways.

Clinical laboratory diagnostic services including:

(i) haematology;

(ii) biochemistry;

(iii) virology;

(iv) microbiology including bacteriology;

(v) immunology;

(vi) cytology with HPV testing where indicated, as per National Cervical Screening Programme guidelines;

(vii) histopathology.

II.2.5) Award criteria

Criteria below:

Quality criterion: Quality / Weighting: 70

Price / Weighting:  30

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 72

This contract is subject to renewal: Yes

Description of renewals:

Initial contract period of 24 months. Two periods of 24 month extensions available. The first period will be agreed by both parties prior to end of the initial period.

II.2.9) Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 4

Objective criteria for choosing the limited number of candidates:

See shortlisting criteria within selection questionnaire notes for completion.

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

The relevant lot specific selection questionnaire for Lot 2: digital pathology can be found at:

https://secure.sourcedogg.com/profile/1410ba09-ae18-49c1-b969-a8d28650cf8c/requests/32227

Lot No: Lot 3

II.2.1) Title

Total (Core Clinical Pathology and Digital Pathology combined)

II.2.2) Additional CPV code(s)

85111800

II.2.3) Place of performance

NUTS code:

UK

UKH

II.2.4) Description of the procurement

Lot 3: total (core clinical pathology and digital pathology combined)

The contract will identify a provider who shall provide a clinical laboratory diagnostic service providing core clinical and an online patient facing platform ordering of sexual health screening kits (Express Test Home STI Kit) for delivery to chosen destination within an overall system of resilient pathology service provision that must, but not limited to, provide:

— meet the service needs of the designated contraception and sexual health services,

— act as an enabler for the delivery of clinical services across iCaSH,

— improve overall user and patient experience and optimise the patient journey, and

— improve clinical outcomes and streamline clinical pathways.

Clinical laboratory diagnostic services including:

(i) haematology;

(ii) biochemistry;

(iii) virology;

(iv) microbiology including bacteriology;

(v) immunology;

(vi) cytology with HPV testing where indicated, as per National Cervical Screening Programme guidelines;

(vii) histopathology.

II.2.5) Award criteria

Criteria below:

Quality criterion: Quality / Weighting: 70

Price / Weighting:  30

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 72

This contract is subject to renewal: Yes

Description of renewals:

Initial contract period of 24 months. Two periods of 24 month extensions available. The first period will be agreed by both parties prior to end of the initial period.

II.2.9) Information about the limits on the number of candidates to be invited

Envisaged number of candidates: 4

Objective criteria for choosing the limited number of candidates:

See shortlisting criteria within selection questionnaire notes for completion.

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

The relevant lot specific selection questionnaire for Lot 3: total (core clinical pathology and digital pathology combined) can be found at: https://secure.sourcedogg.com/profile/1410ba09-ae18-49c1-b969-a8d28650cf8c/requests/32229

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

See requirements of the selection questionnaire and notes for completion document.

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Competitive dialogue

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement with several operators.

Envisaged maximum number of participants to the framework agreement: 2

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2019/S 149-367239

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 06/03/2020

Local time: 12:00

IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates

Date: 01/06/2020

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

VI.3) Additional information

Estimated timeframes:

Competitive dialogue (Lot 1: Core Clinical Pathology and Lot 3: Core Clinical Pathology and Digital Pathology combined)

— contract notice – 20.1.2020 to 24.1.2020 to 6.3.2020,

— selection question – 24.1.2020 to 6.3.2020,

— Invitation to dialogue – 9.3.2020,

— Dialogue session 1 – 17.3.2020 to 20.3.2020,

— Invitation to submit outline solutions (ISOS) – 23.3.2020 to 3.4.2020,

— Dialogue session 2 – 20.4.2020-24.4.2020,

— ISOS Submission – 27.4.2020 to 1.5.2020,

— Dialogue session 3 – 18.5.2020 to 22.5.2020,

— Invitation to submit detailed solution (ISDS) – 25.5.2020 to 29.5.2020,

— Invitation to tender – 1.6.2020 to 12.6.2020,

— Supplier presentations – 20.7.2020,

— Contract award – Sep/Oct 2020,

— Contract start dates – February/March 2021.

Estimated timeframes:

Lot 3: digital

— contract notice – 20.1.2020 to 24.1.2020 to 6.3.2020,

— selection question – 24.1.2020 to 6.3.2020,

— invitation to tender – 1.6.2020 to 12.6.2020,

— Contract award – February 2021,

— Contract start dates – February/March 2021.

NHS Shared Business Services (SBS) is acting as the agent of the contracting authority. SBS does not bind itself or the contracting authority for which it acts as agent, to accept the lowest or any offer and reserves the right to accept an offer either in whole or in part, each item being for this purpose treated as offered separately.

SBS acting as the agent of the contracting authority reserves the right to award contracts for the supply of the goods/services described above and arising out of this procurement process to more than 1 contractor.

VI.4) Procedures for review

VI.4.1) Review body

NHS SBS

Kingfisher House, Hingchingbrooke Business Park

Huntingdon

PE29 6FH

UK

Telephone: +44 1480398500

E-mail: andrew.moore21@nhs.net

Internet address(es)

URL: https://www.sbs.nhs.uk/

VI.5) Date of dispatch of this notice

21/01/2020

Current Notes